首页> 外文OA文献 >1581. In Vitro Activity of Ceftolozane/Tazobactam against Pseudomonas aeruginosa from ICU and Non-ICU Patients with Respiratory Tract Infections in the Asia/Pacific region – SMART 2016-2018

【2h】

1581. In Vitro Activity of Ceftolozane/Tazobactam against Pseudomonas aeruginosa from ICU and Non-ICU Patients with Respiratory Tract Infections in the Asia/Pacific region – SMART 2016-2018

机译：1581.来自ICU和非ICU患者对亚洲/太平洋地区呼吸道感染的ICUDOUDONAS铜绿假单胞菌的体外活性 - 来自亚洲/太平洋地区的呼吸道感染 - 智能2016-2018

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Sibylle Lob; Krystyna Kazmierczak; Wei-Ting Chen; Yivonne Khoo; Kanchan Balwani; Katherine Young; Mary Motyl; Daniel F Sahm;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Antimicrobial activity of ceftolozane-tazobactam tested against Enterobacteriaceae and Pseudomonas aeruginosa collected from patients with bloodstream infections isolated in United States hospitals (2013–2015) as part of the Program to Assess Ceftolozane-Tazobactam Susceptibility (PACTS) surveillance program [J] . Dee Shortridge, Michael A Pfaller, Mariana Castanheira, Diagnostic microbiology and infectious disease . 2018,第2期

机译：Ceftolozane-Tazobactam的抗菌活性对肠杆菌痤疮和假单胞菌铜绿假单胞菌进行测试，并从美国医院（2013-2015）中分离的血流感染患者收集，作为评估头孢唑唑塔布·敏感性（协议）监测计划的方案的一部分
2. Activity of Ceftolozane-Tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae Isolates Collected from Respiratory Tract Specimens of Hospitalized Patients in the United States during 2013 to 2015 [J] . Castanheira Mariana, Duncan Leonard R., Mendes Rodrigo E., Antimicrobial agents and chemotherapy. . 2018,第3期

机译：2013年至2015年从美国住院患者的呼吸道患者呼吸道分子收集的尖灰石 - 妥氮酰亚氨酰胺的活性。
3. Comparison of the In Vitro Susceptibility of Ceftolozane-Tazobactam With the Cumulative Susceptibility Rates of Standard Antibiotic Combinations When Tested Against Pseudomonas aeruginosa From ICU Patients With Bloodstream Infections or Pneumonia [J] . Dee Shortridge, Michael A Pfaller, S J Ryan Arends, Open Forum Infectious Diseases . 2019,第6期

机译：接受ICU血流感染或肺炎患者的铜绿假单胞菌检测时，头孢洛赞他唑巴坦的体外药敏性与标准抗生素组合的累积药敏率比较
4. Antimicrobial activity of ceftolozane-tazobactam against Enterobacterales and Pseudomonas aeruginosa recovered during the Study for Monitoring Antimicrobial Resistance Trends (SMART) program in Spain (2016-2018) [O] . Rafael Cantón, Elena Loza, Ricardo M. Arcay, 2021

机译：Ceftolozane-Tazobactam对肠杆菌和铜绿假单胞菌的抗菌活性在西班牙监测抗菌抗菌趋势（智能）计划期间恢复的铜绿假单胞菌（2016-2018）
5. Ceftolozane/tazobactam and imipenem/relebactam cross-susceptibility among clinical isolates of Pseudomonas aeruginosa from patients with respiratory tract infections in ICU and non-ICU wards – SMART United States 2017-2019 [O] . Sibylle H Lob, Daryl D DePestel, C Andrew DeRyke, 2021

机译：来自ICU和非ICU病房的呼吸道感染患者的临床分离株的头孢尔噻唑胺和IMIPENEM / Creebactam交叉敏感性 - 2017-2019

1581. In Vitro Activity of Ceftolozane/Tazobactam against Pseudomonas aeruginosa from ICU and Non-ICU Patients with Respiratory Tract Infections in the Asia/Pacific region – SMART 2016-2018

著录项

相似文献

相关主题

期刊订阅